← Back to Search

Brain Training + Paced Breathing for Cognitive Impairment (HeartBEAM Trial)

N/A
Waitlist Available
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured from blood draws at lab visits on weeks 2, 7, and 12
Awards & highlights

HeartBEAM Trial Summary

This trial will study how daily paced breathing affects learning and amyloid beta levels in older adults aged 50-70. They'll do memory training, breathing exercises and lab visits.

Eligible Conditions
  • Age-related Cognitive Decline
  • Alzheimer's Disease
  • Aging

HeartBEAM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured from blood draws at lab visits on weeks 2, 7, and 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured from blood draws at lab visits on weeks 2, 7, and 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in plasma Ab42/40 ratio [ Time Frame: Measured from blood draws at lab visits on Weeks 2, 7, and 12 ]
Change in plasma amyloid beta levels
Secondary outcome measures
Brain training performance on 12 Lumosity games during the breathing intervention (controlling for brain training performance pre intervention)
Change in brain perivascular space volume
Change in hippocampal volume
Other outcome measures
Change in plasma pTau-181/tau ratio [ Time Frame: Measured from blood draws at lab visits on Weeks 2, 7, and 12 ]
Body Weight Changes

HeartBEAM Trial Design

2Treatment groups
Experimental Treatment
Group I: Brain training and paced breathing to stimulate alertnessExperimental Treatment2 Interventions
Group II: Brain training and paced breathing to relaxExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brain training
2023
N/A
~100
Paced breathing
2019
N/A
~150

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
915 Previous Clinical Trials
1,603,633 Total Patients Enrolled
1 Trials studying Age-related Cognitive Decline
240 Patients Enrolled for Age-related Cognitive Decline
University of California, IrvineOTHER
546 Previous Clinical Trials
1,923,110 Total Patients Enrolled
1 Trials studying Age-related Cognitive Decline
240 Patients Enrolled for Age-related Cognitive Decline

Media Library

Brain training Clinical Trial Eligibility Overview. Trial Name: NCT05602220 — N/A
Age-related Cognitive Decline Research Study Groups: Brain training and paced breathing to stimulate alertness, Brain training and paced breathing to relax
Age-related Cognitive Decline Clinical Trial 2023: Brain training Highlights & Side Effects. Trial Name: NCT05602220 — N/A
Brain training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05602220 — N/A
~39 spots leftby Jun 2025